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Abstract
Aims/hypothesis The aim of the study was to describe 20-
year incidence trends for childhood type 1 diabetes in 23
EURODIAB centres and compare rates of increase in the first
(1989–1998) and second (1999–2008) halves of the period.
Methods All registers operate in geographically defined
regions and are based on a clinical diagnosis. Completeness
of registration is assessed by capture–recapture methodology.
Twenty-three centres in 19 countries registered 49,969 new
cases of type 1 diabetes in individuals diagnosed before their
15th birthday during the period studied.
Results Ascertainment exceeded 90% in most registers.
During the 20-year period, all but one register showed
statistically significant changes in incidence, with rates uni-
versally increasing. When estimated separately for the first
and second halves of the period, the median rates of increase
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were similar: 3.4% per annum and 3.3% per annum, respec-
tively. However, rates of increase differed significantly be-
tween the first half and the second half for nine of the 21
registers with adequate coverage of both periods; five regis-
ters showed significantly higher rates of increase in the first
half, and four significantly higher rates in the second half.
Conclusions/interpretation The incidence rate of childhood
type 1 diabetes continues to rise across Europe by an average
of approximately 3–4% per annum, but the increase is not
necessarily uniform, showing periods of less rapid and more
rapid increase in incidence in some registers. This pattern of
change suggests that important risk exposures differ over time
in different European countries. Further time trend analysis
and comparison of the patterns in defined regions is warranted.
Keywords Epidemiology . Incidence . Temporal change .
Trends . Type 1 diabetes
Introduction
Recent incidence rate trends in childhood type 1 diabetes have
been well characterised in publications by the EURODIAB
registries in Europe [1] and by the DIAMOND (Diabetes
Mondiale) Project Group worldwide [2]. The DIAMOND
report described increasing trends in nearly every continent
in the 1990s, whereas in Europe there was clear evidence that
relative increases were highest in central and eastern European
countries and in the under-5-year age group during the period
1989–2003.
More recent analyses from Norway [3] and Finland [4]
suggest that rates of increase were lower in the 1980s, with a
subsequent acceleration in the 1990s. The same pattern is
evident in data from Sweden [5], and that analysis addition-
ally raises the possibility that the rapid increase in the 1990s
may soon be reversed, a reduction in rates having been
observed beginning with the 2000 birth cohort.
The EURODIAB group has maintained registers of child-
hood diabetes in a range of European countries since 1989
using standardised methodology and with validation of
completeness of ascertainment, and these observations from
Scandinavia led us to compare incidence rates in the first
half of the 20-year registration period (1989–1998) with
those in the second half (1999–2008).
Methods
Case inclusion criteria were as previously described for the
EURODIAB registers [6]: new diagnoses of type 1 (insulin-
dependent) diabetes mellitus among children aged under
15 years resident in the geographically defined region. The
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completeness of registration was estimated separately in
each of the 10-year periods using capture–recapture meth-
odology [7], which requires that independent primary and
secondary sources of ascertainment are available. In most
centres, the primary source of ascertainment was through
hospital records or notifications by paediatricians and family
doctors, whereas secondary sources varied depending on
local circumstances and included social insurance schemes,
diabetes associations and prescription data.
Annual estimates of the population resident in each
centre’s geographically defined area were used as denomi-
nators for the calculation of directly standardised incidence
rates using a standard population consisting of equal numb-
ers of children in each of six subgroups defined by age
group (0–4, 5–9 and 10–14 years) and sex.
Poisson regression was used to estimate the trends in
incidence rate within centres. For each centre, a model with
terms for age group, sex and an age group×sex interaction
was first fitted. Then either a categorical variable represent-
ing the 5-year subperiods or a linear term testing for trend
across individual years was added to the model to provide
comparisons of incidence rates over time that took account
of changes in the age structure of the population. For three
centres whose registers changed coverage during the period,
separate estimates of trend were fitted for each 10-year
subperiod, and the two estimates were compared by likeli-
hood ratio test. For the remaining centres, a similar model
was fitted but with the added constraint that the fitted lines
should meet between 1998 and 1999. Models were fitted
using Stata Release 11 (Stata, College Station, TX, USA).
Table 1 Age and sex standardised rates of type 1 diabetes diagnosed before 15 years of age in four five year periods for 23 EURODIAB centres
from 19 countries in Europe
Centre Region Period Number
of cases
Standardised incidence rate per 100,000a
P1 P2 P3 P4b
Austria Whole nation 1989–2008 3372 9.0 9.9 13.3 17.5
Belgium Antwerp 1989–2008 448 10.9 12.9 15.5 15.9
Croatia Zagreb 1989–2008 339 6.7 6.4 8.2 10.4
Czech Republic Whole nation 1989–2008 4883 8.5 11.5 17.0 19.3
Denmarkc 1) Four counties 1989–1998 385 17.0 16.3 – –
2) Whole nation 1999–2008 2402 – – 22.6 25.1
Germany Baden Württemberg 1989–2007 4804 11.0 13.0 15.4 21.8d
Germanyc 1) Düsseldorf (seven districts) 1989–1998 595 13.3 16.8 – –
2) North Rhine-Westphalia 1999–2008 6331 – – 21.3 23.7
Germany Saxony 1998–2008 921 – 11.6d 15.6 20.1
Hungary 18 counties 1989–2008 3239 9.0 10.7 12.4 18.3
Lithuania Whole nation 1989–2008 1396 7.3 8.2 10.3 14.2
Luxembourg Whole nation 1989–2008 229 11.4 12.3 15.5 19.0
Macedonia Whole nation 1989–2008 447 3.2 3.9 5.6 5.8
Montenegro Whole nation 1996–2008 252 – 10.1d 14.0 17.5
Norwayc 1) Eight counties 1989–2003 1380 21.1 20.5 24.6 –
2) Whole nation 2004–2008 1504 – – – 32.8
Poland Katowice 1989–2008 1719 5.2 7.9 12.9 16.5
Romania Bucharest 1989–2008 534 4.7 6.1 11.3 14.5
Slovenia Whole nation 1989–2008 715 7.9 9.2 11.1 14.6
Spain Catalonia 1989–2008 2527 12.4 13.6 12.9 12.1
Sweden Stockholm county 1989–2008 1978 25.8 25.6 34.5 36.6
Switzerland Whole nation 1991–2008 2220 8.0d 8.3 11.0 13.1
United Kingdom Northern Ireland 1989–2008 2043 20.0 24.7 29.8 33.9
United Kingdom Oxford 1989–2008 2288 17.2 21.7 24.0 25.1
United Kingdom Yorkshire 1989–2008 3018 16.1 19.7 23.5 25.5
a Standard population with six age-sex subgroups of equal size
b Periods denoted P1: 1989–1993, P2: 1994–1998, P3: 1999–2003, P4: 2004–2008
c In three registries, period 2) has extended geographic coverage compared with period 1)
d Rate based on registration data for only part of the period
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The Joinpoint regression program (Version 3.5 – April
2011; Statistical Methodology and Applications Branch and
Data Modeling Branch, Surveillance Research Program Na-
tional Cancer Institute, Bethesda, MD, USA) specifically
designed for surveillance of trends in cancer incidence, was
also used to see how sensitive conclusions were to the arbi-
trary division of the period into two 10-year subperiods. Join-
point provides greater flexibility by accommodating the fitting
of two or more linear segments that join at time points that are
estimated from the data. The program provides a permutation
test to assess the number of linear segments and the times at
which they join, while taking into account the multiple testing
issues inherent in the approach. A less conservative Bayesian
information criterion for model selection was also employed.
In order that Joinpoint should mimic as closely as possible the
Poisson regression approach, the log-linear model option was
chosen, and heteroscedasticity was taken into account by
using the standard error of the annual standardised rates.
Further details are provided in the electronic supplemen-
tary material [ESM] Statistical methods.
Table 2 Completeness of ascertainment and estimated annual rates of increase compared in the two 10-year periods 1989–1998 and 1999–2008 for
23 EURODIAB centres
Centre Region Completeness of ascertainment, % Rates of increase per annum, %a (95 % CI)
1989–1998:1999–2008 1989–1998 : 1999–2008 p value
Austria Whole nation 99.8 : 97.2 3.3 (1.8,4.8) : 6.1 (4.8,7.4) 0.03*
Belgium Antwerp 98.·6 : 94.·9 3.3 (–0.6,7.4) : 1.9 (–1.6,5.5) 0.68
Croatia Zagreb 99.7 : 100.0 0.1 (–4.3,4.7) : 6.8 (2.7,11.0) 0.09
Czech Republic Whole nation 99.9 : 97.4 7.6 (6.3,8.8) : 3.9 (2.9,5.0) 0.001*
Denmarkb 1) Four counties 99.1 :― 0.5 (–2.9,4.1)c : ― 0.56c
2) Whole nation ― : 99.2d ― : 1.7 (0.2,3.1)c
Germany Baden Württemberg 97.2 : 100.0 2.9 (1.7,4.2) : 6.5 (5.3,7.7)e 0.002*
Germanyb 1) Düsseldorf (seven districts) 94.0 : ― 6.1 (3.2,9.2)c : ― 0.01*c
2) North Rhine–Westphalia ― : 98.6 ― : 2.1 (1.3,3.0)c
Germany Saxony ― : 93.6d ― : 4.6 (2.2,7.1) ―
Hungary 18 counties 97.1 : 98.7 3.2 (1.8,4.7) : 5.8 (4.5,7.2) 0.04*
Lithuania Whole nation 100.0 : n/a 2.1 (–0.1,4.3) : 7.2 (5.1,9.3) 0.009*
Luxembourg Whole nation 100.0 : 100.0 0.9 (–4.7,6.8) : 5.8 (0.9,10.8) 0.32
Macedonia Whole nation 94.9 : 100.0 6.4 (2.2,10.7) : 2.9 (–0.5,6.5) 0.33
Montenegro Whole nation 100.0 : 100.0 ― : 6.5 (1.6,11.7) ―
Norwayb 1) Eight counties 100.0 :― –1.2(–3.5,1.1)c : ― 0.42c
2) Whole nation ― : 92.0d ― : 0.5 (–3.0,4.2)c,e
Poland Katowice 99.9 : n/a 10.7 (8.3,13.1) : 5.5 (3.7,7.3) 0.006*
Romania Bucharest 100.0 : 100.0 8.0 (4.3,12.0) : 7.8 (4.4,11.2) 0.93
Slovenia Whole nation 100.0 : 100.0 4.1 (1.0,7.2) : 3.9 (1.1,6.8) 0.96
Spain Catalonia 89.4 : 97.6 0.9 (–0.5,2.4) : –1.4 (–2.9,0.1) 0.09
Sweden Stockholm county 100.0 : n/a 2.5 (0.6,4.5) : 2.5 (0.9,4.2) 0.66
Switzerland Whole nation 91.7d: 91.3d 2.1 (–0.3,4.5)e : 5.4 (3.8,7.0) 0.07
UK Northern Ireland 99.5 : 99.5 4.6 (2.7,6.5) : 2.8 (1.2,4.5) 0.27
UK Oxford n/a : n/a 4.0 (2.3,5.8) : 0.4 (–1.1,2.0) 0.02*
UK Yorkshire 99.0 : 99.6 4.7 (3.1,6.3) : 1.6 (0.3,2.9) 0.02*
a Derived from Poisson regression model estimates of log-linear trends constraining lines to meet between 1998 and 1999 (see ESM Statistical
methods)
b In three registries, period 2) has extended geographic coverage compared with period 1)
c Rates of increase in periods 1) and 2) were estimated and compared without constraining the fitted log-linear trends to meet between 1998 and 1999
d Estimate was obtained independently of the EURODIAB study
e Rate of increase was based on registration data for only part of the period
*p<0.05
n/a, not available
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Results
Table 1 shows the total numbers of cases registered during
the 20-year period 1989–2008 in each of the 23 centres, and
the age- and sex-standardised incidence rates in the four 5-
year subperiods 1989–1993, 1994–1998, 1999–2003 and
2004–2008. The age- and sex-specific incidence rates used
in the calculations are available in ESM Table 1. Investigation
of changes in incidence during the period was complicated in
Denmark and Norway because the registers changed from
regional to national coverage, and in Germany because of
the extension of the Düsseldorf register to cover the whole
North Rhine–Westphalia region. Poisson regression analysis
confirmed that there were significant differences in the age-
standardised rates between the four periods in all remaining
centres with the exception of Catalonia (Spain), and incidence
rates were universally observed to increase.
In Table 2 estimates of completeness of ascertainment
obtained by the capture–recapture method are presented in
the two 10-year periods 1989–1998 and 1999–2008 (for
further details, see ESM Table 2). In most centres, greater
than 90% ascertainment was maintained in both periods,
with many achieving in excess of 95% ascertainment. The
estimated annual increases (with 95% confidence intervals)
in the first and second 10-year periods are given in the final
columns. Comparison of these rates of increase showed a
significant acceleration in the rate of increase in four centres
(Austria, Germany [Baden Württemberg], Hungary and
Lithuania) and a significant deceleration in the rate of in-
crease in five centres (Czech Republic, Germany [Düssel-
dorf/North Rhine–Westphalia], Poland [Katowice] and the
UK [Oxford and Yorkshire]). The median rates of increase
over all the centres changed little, from 3.4% per annum in
1989–1998 to 3.3% per annum in 1999–2008.
Using the default permutation test settings, the Joinpoint
program detected significant departures from a uniform log-
linear trend with time for two of the largest centres that our
analyses had identified – the Czech Republic, with a join
between two log-linear segments in 2000, and Germany
(Baden Württemberg), with a join in 2002. Using the alter-
native and less conservative Bayesian Information Criterion
settings, the program detected departures from uniform log-
linear trend with time in a further five of the centres identi-
fied by our analysis – Austria, Hungary, Lithuania, Poland
(Katowice) and the UK (Yorkshire).
Discussion
The incidence rate of childhood type 1 diabetes continues to
rise across Europe by approximately 3–4% per annum, but
the increase is not necessarily uniform, with periods of less
rapid and more rapid increase in incidence occurring in
many registers. Although such patterns of change in inci-
dence rate have previously been described in Scandinavian
countries, our analysis suggests that the same phenomenon
is also occurring in other parts of Europe.
Although our analysis may be criticised for comparing two
arbitrarily selected 10-year periods, the finding of significant
differences in the rates of increase in nine of the 21 centres for
which the comparison was possible does suggest that these
changes in rate are not an artefact, particularly since the
completeness of registration was uniformly high in most of
these centres. The Joinpoint program provided broad confir-
mation of our findings, but only when the less conservative
Bayesian Information Criterion was used for model selection.
The possibility that changes in trends are affecting dif-
ferent age groups at different times cannot be ruled out. Use
of age–period–cohort models has the potential to address
this issue, but long-term data over broad age ranges are
necessary for this technique to provide useful conclusions
[8], and there are well-recognised difficulties in separating
period and cohort effects when the predominant pattern of
change is one of a log-linear increase [9].
Given the changing trends over time observed within
individual centres in our analysis, forecasting future numb-
ers of cases of type 1 diabetes in children by extrapolating
past trends in a single centre or country could be misleading,
and a better general strategy may be to derive trend esti-
mates from groups of geographically adjacent countries with
broadly similar incidence rates when attempting such
extrapolations [1].
Our findings suggest that important environmental risk
exposures are changing over time in different ways across
European countries. Further time trend analysis and comparison
of the patterns in different regions within Europe are warranted.
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